Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-30 @ 4:47 PM
Study NCT ID:
NCT04628169
Status:
COMPLETED
Last Update Posted:
2024-09-20
First Post:
2020-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum
Sponsor:
Assiut University
Organization:
Study Overview
Official Title:
Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main goal of this study is to assess the role of Netrin 1, neogenin and ZEB1 in PAS-associated invasion
Detailed Description:
* To evaluate the immunohistochemical expression of these proteins in PAS specimens in comparison with the control placental tissues.
* To correlate their expression with the demographic parameters.
* To assess the correlation between their expression in PAS specimens.
* To correlate their expression with the demographic parameters.
* To assess the correlation between their expression in PAS specimens.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: